Medicine guide
Thelin
·
- Prescription status not stated
- Heart, blood pressure and circulation
- Active substance
- Sitaxentan sodium
- Made by
- Pfizer Ltd.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of patients with pulmonary arterial hypertension (PAH) classified as WHO functional class III, to improve exercise capacity. Efficacy has been shown in primary pulmonary hypertension and in pulmonary hypertension associated with connective tissue disease.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Pfizer Ltd. |
|---|---|
| Active substance | Sitaxentan sodium |
| Used in | Heart, blood pressure and circulation |
| Classification | C02KX03 · Heart, blood pressure and circulation |
| Authorised on | 2006-08-10 |
| Last updated by the regulator | 2011-03-02 |
| EMA product number | EMEA/H/C/000679 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).